MiRus Gains FDA 510(k) for IO Expandable Lumbar Interbody

MiRus received FDA 510(k) clearance to market its IO™ Expandable Lumbar Interbody.

The device can be used in both PLIF and TLIF procedures. It features the lowest insertion profile (4mm) and greatest expansion (18mm) and lordosis (24◦) in a single implant of any expandable interbody on the market. In addition to the one-step expansion, the implant allows for 2.5cc of biologic to be post-packed in the intervertebral space.

Powered by the MoRe® expansion engine, the IO Expandable Lumbar Interbody allows minimization of insertion height and maximization of expansion height, lordosis thus making it easier for surgeons to restore lordosis, maintain sagittal balance while reducing the challenges of insertion and related neural injury.

FDA 510(k) clearance allows the IO™ Expandable Lumbar Interbody to be used in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L1-L2 to L5-S1.

Source: MiRus